MedTrace Logo

Gonyautoxin in the Treatment of Chronic Tension-Type Headache

NCT00276952 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2006-01-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical efficacy of Gonyautoxin 2/3 epimers in the treatment of patients diagnosed with chronic tensional-type headache in accordance with International Headache Society guidelines

Conditions

  • Tension-Type Headache

Interventions

DRUG

Gonyautoxin

Sponsors & Collaborators

  • University of Chile

    lead OTHER

Principal Investigators

  • Nestor Lagos, PhD · Faculty of Medicine University of Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Completion
2005-08-31

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00276952 on ClinicalTrials.gov